Phenotypic screening: The future of antibody discovery

Drug Discovery Today

Volumn 21, Issue 1, 2016, Pages 150-156

  Gonzalez Munoz, Andrea L ^a   Minter, Ralph R ^a   Rust, Steven J ^a  

^a MEDIMMUNE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALEMTUZUMAB; ANTIINFECTIVE AGENT; ANTINEOPLASTIC AGENT; HYBRIDOMA DERIVED ANTIBODY; MONOCLONAL ANTIBODY; UNCLASSIFIED DRUG; ANTIBODY;

ANTIBODY LIBRARY; DRUG ISOLATION; DRUG SCREENING; HIGH THROUGHPUT SCREENING; HUMAN; NEOPLASM; NONHUMAN; PHENOTYPE; REVIEW; ANIMAL; DRUG DEVELOPMENT; MASS SCREENING; NEOPLASMS; PROCEDURES;

ANIMALS; ANTIBODIES; DRUG DISCOVERY; HUMANS; MASS SCREENING; NEOPLASMS; PHENOTYPE;

EID: 84960355587     PISSN: 13596446     EISSN: 18785832     Source Type: Journal    
DOI: 10.1016/j.drudis.2015.09.014     Document Type: Review

References (60)

1. J.M. Reichert Antibodies to watch in 2015 MAbs 7 2015 1 8
2. A.L. Nelson, and et al. Development trends for human monoclonal antibody therapeutics Nat. Rev. Drug Discov. 9 2010 767 774
3. H.R. Hoogenboom Selecting and screening recombinant antibody libraries Nat. Biotechnol. 23 2005 1105 1116
4. M.R. Duvall, and R.N. Fiorini Different approaches for obtaining antibodies from human B cells Curr. Drug Discov. Technol. 11 2014 41 47
5. A.J. Smith New horizons in therapeutic antibody discovery: opportunities and challenges versus small molecule therapeutics J. Biomol. Screen. 20 2014 437 453
6. A. Beck Biosimilar, biobetter and next generation therapeutic antibodies MAbs 3 2011 107 110
7. D.C. Swinney, and J. Anthony How were new medicines discovered? Nat. Rev. Drug Discov. 10 2011 507 519
8. D.T. Loo, and J.P. Mather Antibody-based identification of cell surface antigens: targets for cancer therapy Curr. Opin. Pharmacol. 8 2008 627 631
9. D. Sánchez-Martín, and et al. Selection strategies for anticancer antibody discovery: searching off the beaten path Trends Biotechnol. 33 2015 292 301
10. D. Corti, and A. Lanzavecchia Efficient methods to isolate human monoclonal antibodies from memory B cells and plasma cells Microbiol. Spectrum 2 2014 1 9
11. J. de Kruif, and et al. Rapid selection of cell subpopulation-specific human monoclonal antibodies from a synthetic phage antibody library Proc. Natl. Acad. Sci. U. S. A. 92 1995 3938 3942
12. C.G. Jakobsen, and et al. Phage display derived human monoclonal antibodies isolated by binding to the surface of live primary breast cancer cells recognize GRP78 Cancer Res. 67 2007 9507 9517
13. G. Kurosawa, and et al. Selection and analysis of anti-cancer antibodies for cancer therapy obtained from antibody phage library Cancer Sci. 102 2011 175 181
14. P. Orecchia, and et al. A novel human anti-syndecan-1 antibody inhibits vascular maturation and tumour growth in melanoma Eur. J. Cancer 49 2013 2022 2033
15. J. Fransson, and et al. Rapid induction of apoptosis in B-cell lymphoma by functionally isolated human antibodies Int. J. Cancer 119 2006 349 358
16. D.T. Dudley, and et al. A 3D matrix platform for the rapid generation of therapeutic anti-human carcinoma monoclonal antibodies Proc. Natl. Acad. Sci. U. S. A. 111 2014 14882 14887
17. M.A. Poul, and et al. Selection of tumor-specific internalizing human antibodies from phage libraries J. Mol. Biol. 301 2000 1149 1161
18. S. Rust, and et al. Combining phenotypic and proteomic approaches to identify membrane targets in a 'triple negative' breast cancer cell type Mol. Cancer 12 2013 11
19. Young, D.S.F. et al. Chimeric and humanized anti-cd44 antibodies that mediate cancer cell cytotoxicity, F. Hoffmann-La Roche Ag. US7189397
20. L. da Cruz, and et al. Anti-CD44 antibody, ARH460-16-2, binds to human AML CD34+CD38- cancer stem cells and shows anti-tumor activity in an AML xenograft model AACR Meeting Abstracts 3976 2008
21. F. Birzele, and et al. CD44 isoform status predicts response to treatment with anti-CD44 antibody in cancer patients Clin. Cancer Res. 21 2015 2753 2762
22. S. Zhang, and et al. Targeting chronic lymphocytic leukemia cells with a humanized monoclonal antibody specific for CD44 Proc. Natl. Acad. Sci. U. S. A. 110 2013 6127 6132
23. Young, D.S.F. et al. Individualized patient-specific anti-cancer antibodies, Arius Research, Inc. US6180357
24. D. Loo, and et al. The glycotope-specific RAV12 monoclonal antibody induces oncosis in vitro and has antitumor activity against gastrointestinal adenocarcinoma tumor xenografts in vivo Mol. Cancer Ther. 6 2007 856 865
25. S.K. Coberly, and et al. The RAV12 monoclonal antibody recognizes the N-linked glycotope RAAG12: expression in human normal and tumor tissues Arch. Pathol. Lab. Med. 133 2009 1403 1412
26. M. Hay, and et al. Clinical development success rates for investigational drugs Nat. Biotechnol. 32 2014 40 51
27. D.C. Swinney Phenotypic vs. target-based drug discovery for first-in-class medicines Clin. Pharmacol. Ther. 93 2013 299 301
28. T.J. Vaughan, and et al. Human antibodies with sub-nanomolar affinities isolated from a large non-immunized phage display library Nat. Biotechnol. 14 1996 309 314
29. A. Knappik, and et al. Fully synthetic human combinatorial antibody libraries (HuCAL) based on modular consensus frameworks and CDRs randomized with trinucleotides J. Mol. Biol. 11 2000 57 86
30. N. Veitonmaki, and et al. A human ICAM-1 antibody isolated by a function-first approach has potent macrophage-dependent antimyeloma activity in vivo Cancer Cell 23 2013 502 515
31. B. Frendéus Function-first antibody discovery: embracing the unpredictable biology of antibodies OncoOmmunology 2 2013 e25047
32. M. Hansson, and et al. A Phase I dose-escalation study of antibody BI-505 in relapsed/refractory multiple myeloma Clin. Cancer Res. 21 2015 2730 2736
33. A. DiGiandomenico, and et al. Identification of broadly protective human antibodies to Pseudomonas aeruginosa exopolysaccharide Psl by phenotypic screening J. Exp. Med. 209 2012 1273 1287
34. A. DiGiandomenico, and et al. A multifunctional bispecific antibody protects against Pseudomonas aeruginosa Sci. Transl. Med. 6 2014 262ra155
35. J.S. McLellan, and et al. Structure of RSV fusion glycoprotein trimer bound to a prefusion-specific neutralizing antibody Science 340 2013 1113 1117
36. A. Macagno, and et al. Isolation of human monoclonal antibodies that potently neutralize human cytomegalovirus infection by targeting different epitopes on the gH/gL/UL128-131A complex J. Virol. 84 2010 1005 1013
37. H. Reikvam, and et al. Targeted anti-leukemic therapy as disease-stabilizing treatment for acute myeloid leukemia relapse after allogeneic stem cell transplantation: Will it be possible to combine these strategies with retransplantation or donor lymphocyte infusions? Curr. Cancer. Drug Targets 13 2013 30 47
38. L. Xu, and et al. A mammalian expression system for high throughput antibody screening J. Immunol. Methods 395 2013 45 53
39. H. Zhang, and et al. Selection of antibodies that regulate phenotype from intracellular combinatorial antibody libraries Proc. Natl. Acad. Sci. U. S. A. 109 2012 15728 15733
40. J. Xie, and et al. Autocrine signaling based selection of combinatorial antibodies that transdifferentiate human stem cells Proc. Natl. Acad. Sci. U. S. A. 110 2013 8099 8104
41. H. Zhang, and et al. Selecting agonists from single cells infected with combinatorial antibody libraries Chem. Biol. 20 2013 734 7341
42. A.N. Melidoni, and et al. Selecting antagonistic antibodies that control differentiation through inducible expression in embryonic stem cells Proc. Natl. Acad. Sci. U. S. A. 110 2013 17802 17807
43. A.N. Melidoni, and et al. Selection of antibodies interfering with cell surface receptor signalling using embryonic stem cell differentiation Methods Mol. Biol. 2015 10.1007/7651-2015-270
44. J. Xie, and et al. Prevention of cell death by antibodies selected from intracellular combinatorial libraries Chem. Biol. 21 2014 274 283
45. K. Yea, and et al. Converting stem cells to dendritic cells by agonist antibodies from unbiased morphogenic selections Proc. Natl. Acad. Sci. U. S. A. 110 2013 14966 14971
46. E. Mazuc, and et al. In-cell intrabody selection from a diverse human library identifies C12orf4 protein as a new player in rodent mast cell degranulation PLOS ONE 9 2014 e104998
47. T.C. Wilkinson, and et al. Discovery of functional antibodies targeting ion channels J. Biomol. Screen. 20 2015 454 467
48. H. Sun, and M. Li Antibody therapeutics targeting ion channels: are we there yet? Acta Pharmacol. Sin. 34 2013 199 204
49. S. Ridges, and et al. Zebrafish screen identifies novel compound with selective toxicity against leukemia Blood 119 2012 5621 5631
50. A.N. Shah, and et al. Rapid reverse genetic screening using CRISPR in zebrafish Nat. Methods 12 2015 535 540
51. V.E. Gallardo, and et al. Phenotype-driven chemical screening in zebrafish for collective cell migration inhibitors identifies multiple potential pathways for targeting metastasis Dis. Model. Mech. 8 2015 565 576
52. A.J. Rennekamp, and R.T. Peterson 15 years of zebrafish chemical screening Curr. Opin. Chem. Biol. 24 2015 58 70
53. M.J. Bissell, and et al. Tissue architecture: the ultimate regulator of breast epithelial function Curr. Opin. Cell Biol. 15 2003 753 762
54. A. Sandercock, and et al. Identification of anti-tumour biologics using primary tumour models, 3-D phenotypic screening and image-based multi-parametric profiling Mol. Cancer 14 2015 147
55. D. Huh, and et al. A human disease model of drug toxicity-induced pulmonary edema in a lung-on-a-chip microdevice Sci. Transl. Med. 4 2012 159ra147
56. A.R. Aref, and et al. Screening therapeutic EMT blocking agents in a three-dimensional microenvironment Integr. Biol. 5 2013 381 389
57. H. Waldmann, and G. Hale CAMPATH: from concept to clinic Philos. Trans. R. Soc. Lond. B: Biol. Sci. 360 2005 1707 1711
58. M.J. Dyer, and et al. Effects of CAMPATH-1 antibodies in vivo in patients with lymphoid malignancies: influence of antibody isotype Blood 73 1989 1431 1439
59. H. Waldmann, and et al. Elimination of graft-versus-host disease by in-vitro depletion of alloreactive lymphocytes with a monoclonal rat anti-human lymphocyte antibody (CAMPATH-1) Lancet 2 1984 483 486
60. M.Q. Xia, and et al. Characterization of the CAMPATH-1 (CDw52) antigen: biochemical analysis and cDNA cloning reveal an unusually small peptide backbone Eur. J. Immunol. 21 1991 1677 1684